ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

Fox Retirement Marks End of Era for NCI Construction Program

October 6, 1989

Summit Tells Women To Get A Mammogram, Encourages Others, Too

September 29, 1989

UCLA Comp Center status Near, But There Are Problems

October 22, 1976

Cooperative Group-cancer control Program To Continue

August 10, 1979

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

In Brief: Bleyer To Chair Childrens Cancer Study Group; Fisher To Advise; Penn. Awards Herberman

May 3, 1991